Clinical Trial Update: Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer [Phase 3]

View source ↗

Summary

Phase 3 trial update for fluciclovine (18F) PET/CT in biochemical recurrence of prostate cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• fluciclovine (18F) PET/CT (fluciclovine (18F))

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Cancer of the Prostate | Phase 3 | Status: COMPLETED | Results posted: 2019-10-07